Kitsada Wudhikarn

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “A Day 14 Endpoint for Acute GVHD Clinical Trials”.

A Day 14 Endpoint for Acute GVHD Clinical Trials

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.01.079

N/A

0.373DataRank · unranked

11 citations

Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo‐Hiraldo +36 more

DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality

Blood Advances(2020)10.1182/bloodadvances.2020001972

N/A

0DataRank · unranked

137 citations

Martina Pennisi, Marta García‐Recio, Jessica Flynn, Aishat Olaide Afuye, Mari Lynne Silverberg +12 more

The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy

Transplantation and Cellular Therapy(2020)10.1016/j.jtct.2020.10.022

N/A

0DataRank · unranked

47 citations

Kitsada Wudhikarn, Martina Pennisi, Rosalía Alonso, Jessica Flynn, Roni Shouval +17 more

Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy

Bone Marrow Transplantation(2022)10.1038/s41409-022-01756-w

N/A

0DataRank · unranked

132 citations

Miguel‐Angel Perales, Kitsada Wudhikarn

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

Blood Advances(2022)10.1182/bloodadvances.2022008294

N/A

0DataRank · unranked

42 citations

Ana Alarcón Tomás, Jessica Flynn, Sean M. Devlin, Jamie Brower, Veronika Bachanová +10 more

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Blood Advances(2024)10.1182/bloodadvances.2024012800

N/A

0DataRank · unranked

4 citations

Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long +46 more

Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis

UNC Libraries(2024)10.17615/d5s2-9s76

N/A

0DataRank · unranked

0 citations

Peter A. Riedell, R. Alejandro Sica, Tania Jain, Brian T. Hill, Craig S. Sauter +24 more

Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

Blood Advances(2025)10.1182/bloodadvances.2025016141

N/A

0DataRank · unranked

15 citations

Megan M. Herr, Min Chen, Michael J. Martens, John H. Baird, Lohith Gowda +32 more

Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis

Blood Advances(2025)10.1182/bloodadvances.2025016149

N/A

0DataRank · unranked

5 citations

Prakash Satwani, Megan M. Herr, Min Chen, Michael J. Martens, Kitsada Wudhikarn +26 more

Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma

Blood Cancer Journal(2020)10.1038/s41408-020-00346-7

N/A

0DataRank · unranked

264 citations

M. Lia Palomba, Martina Pennisi, Marta García‐Recio, Jessica Flynn, Sean M. Devlin +13 more

New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024015599

N/A

0DataRank · unranked

5 citations

Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Temitope Oloyede +40 more